Children whispering
Empowering Life

In the journey to good health, you
need the right partner

Our Stories…

Children playing hide & seek

Committed to a polio-free India

Every 2nd child in India receives Sanofi Pasteur’s Inactivated Polio Vaccine (IPV).
rare diseases

Fighting rare diseases together

Addressing the challenges faced by patients with rare diseases.
A boy talking to someone with cold drink on the table

Sheer grit in the face of adversity

Type 1 diabetes doesn’t mean the end of the world,” - Eshaan Shevate.

About us

100,000+ employees representing 145 nationalities, striving to provide healthcare solutions in 170+ countries!

In India since 1956, we offer innovative solutions in preventive healthcare (vaccines) as well as in treatment for allergy, pain, diabetes, rare diseases, and other therapeutic areas.

Why join Sanofi?

Man standing with folded hands and staring in the camera

“It’s a life changing moment when you realize that you don’t just provide solutions, you actually change and impact lives.”

Snighdhamoy Sengupta
Marketing Manager, Central Nervous System

Be a part of Sanofi

Media Release


Shantha Biotechnics’ Inactivated Polio Vaccine – ShanIPV™ prequalified by the World Health Organization (WHO)

Our Inactivated Polio Vaccine - ShanIPV™ received prequalification status from the World Health Organization (WHO). This status qualifies ShanIPV™ vaccine for purchase by the United Nations’ agencies.
Pain clinics logo

Combiflam® Range of Pain Relief Solutions introduces Pain Education Campaign in Bihar

Pain clinics comprises a series of doctor and pain expert videos that educate people to treat pain in an informed and responsible manner.
2018-10-10MMMM DD YYYY
Photo of Aubagio tablets

Sanofi launches ‘Aubagio®’ for treatment of Multiple Sclerosis in India

Offers patients diagnosed with Multiple Sclerosis the efficacy and convenience of once-a-day oral treatment.

Contact for medical information or pharmacovigilance

For reporting adverse events:

For medical information (healthcare professionals only):


All consumers or patients are advised to contact their doctor or healthcare professional for advice on medicines or any health matters/medical emergencies.

Pharmacovigilance remains a key activity in the assessment of the therapeutic value of products. Sanofi ensures continuous monitoring and management of the safety profile of all its products through its drug safety data collection worldwide. A key activity of Sanofi is to provide updated medical information in compliance with Indian regulations, on its products, to healthcare professionals.

You can email or call us between 9AM and 5PM on any working day (we are closed on Saturday, Sunday and public holidays). Please select IVRS option 1 for medical information and IVRS option 3 for reporting adverse events.